Another major goal of drug development is to recommend a dose and dosing schedule for first use in a human clinical trial (“first in human” [FIH] or first human dose [FHD]). , formerly called “first in man” [FIM]).
Lengo lingine kuu la utengenezaji wa dawa ni kupendekeza dozi na ratiba ya matumizi ya kwanza katika jaribio la matibabu kwa binadamu (&quot;kwanza katika binadamu: [FIH] au Dozi ya Kwanza ya Binadamu [FHD], iliyojulikana awali kama &apos;kwanza katika binadamu&quot; [FIM]).